Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sintx Technologies ( (SINT) ) has shared an update.
SINTX Technologies has appointed Gregg R. Honigblum as Chief Strategy Officer to spearhead strategic growth and investor relations. With over 35 years in healthcare investment banking, Honigblum has a track record of raising significant capital for innovative ventures, including early-stage companies like Myriad Genetics. His expertise is expected to bolster SINTX’s position in the medical device sector, enhancing shareholder value and driving corporate strategy forward.
For an in-depth examination of SINT stock, go to TipRanks’ Stock Analysis page.